Global and China Molecular Diagnostics in Cancer Testing Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Molecular Diagnostics in Cancer Testing industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • HTG Molecular Diagnostics

    • Exact Sciences Corporation

    • bioTheranostics (AviaraDx)

    • Nuvera Biosciences

    • Abbott Molecular Diagnostics

    • LabCorp

    • Genoptix (Novartis)

    • Pathway Genomics

    • Neogenomics

    • Cancer Genetics

    • Agendia

    • Counsyl

    • Biodesix

    • Exiqon

    • Accugenomics

    • Epigenomics

    • Invitae

    • Nanostring

    • NSTG

    • Genomic Health

    • Myriad Genetics

    • Genomictree

    • Genmark Diagnostics

    • Ambry Genetics

    • Orion Genomics

    • Flatiron Health

    • bioMerieux

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Type 1

    • Type 2

    • Type 3

    Application:

    • Application 1

    • Application 2

    • Application 3

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Molecular Diagnostics in Cancer Testing Industry Overview

      • 1.1.1 Molecular Diagnostics in Cancer Testing Market Scope and Market Segments

      • 1.1.2 Molecular Diagnostics in Cancer Testing Industry Characteristics

      • 1.1.3 Global and China Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Molecular Diagnostics in Cancer Testing Production Value and Growth Rate (2017-2028)

    • 1.2 Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Type 1

      • 1.2.2 Type 2

      • 1.2.3 Type 3

    • 1.3 Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Application 1

      • 1.3.2 Application 2

      • 1.3.3 Application 3

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Molecular Diagnostics in Cancer Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Molecular Diagnostics in Cancer Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Molecular Diagnostics in Cancer Testing Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Molecular Diagnostics in Cancer Testing Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Molecular Diagnostics in Cancer Testing Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Molecular Diagnostics in Cancer Testing Industry Porter's Five Forces Model Analysis

      • 2.2.3 Molecular Diagnostics in Cancer Testing Industry PEST Analysis

    • 2.3 Molecular Diagnostics in Cancer Testing Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Molecular Diagnostics in Cancer Testing Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Molecular Diagnostics in Cancer Testing Industry

    Chapter 3 Global and China Molecular Diagnostics in Cancer Testing Market, by Manufacturer

    • 3.1 Global and China Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Molecular Diagnostics in Cancer Testing Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Molecular Diagnostics in Cancer Testing Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Molecular Diagnostics in Cancer Testing Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Molecular Diagnostics in Cancer Testing Market Top 3 Players

    Chapter 4 Global and China Molecular Diagnostics in Cancer Testing Market, by Type (2017-2028)

    • 4.1 Molecular Diagnostics in Cancer Testing Market Trend, by Type

    • 4.2 Global Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Molecular Diagnostics in Cancer Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Molecular Diagnostics in Cancer Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Molecular Diagnostics in Cancer Testing Price Trend, by Type (2017-2028)

    • 4.3 China Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Molecular Diagnostics in Cancer Testing Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Molecular Diagnostics in Cancer Testing Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Molecular Diagnostics in Cancer Testing Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Molecular Diagnostics in Cancer Testing Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Molecular Diagnostics in Cancer Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Molecular Diagnostics in Cancer Testing Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Molecular Diagnostics in Cancer Testing Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Molecular Diagnostics in Cancer Testing Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Molecular Diagnostics in Cancer Testing Market Analysis

    • 7.1 North America Molecular Diagnostics in Cancer Testing Market, by Type

    • 7.2 North America Molecular Diagnostics in Cancer Testing Market, by Application

    • 7.3 North America Molecular Diagnostics in Cancer Testing Market Analysis and Forecast, by Country

      • 7.3.1 United States Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Molecular Diagnostics in Cancer Testing Market Analysis

    • 8.1 Europe Molecular Diagnostics in Cancer Testing Market, by Type

    • 8.2 Europe Molecular Diagnostics in Cancer Testing Market, by Application

    • 8.3 Europe Molecular Diagnostics in Cancer Testing Market Analysis and Forecast, by Country

      • 8.3.1 Germany Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Molecular Diagnostics in Cancer Testing Market Analysis

    • 9.1 APAC Molecular Diagnostics in Cancer Testing Market, by Type

    • 9.2 APAC Molecular Diagnostics in Cancer Testing Market, by Application

    • 9.3 APAC Molecular Diagnostics in Cancer Testing Market Analysis and Forecast, by Country

      • 9.3.1 China Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Market Analysis

    • 10.1 Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Market, by Type

    • 10.2 Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Market, by Application

    • 10.3 Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Molecular Diagnostics in Cancer Testing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Molecular Diagnostics in Cancer Testing Company Profiles

      • 11.1 HTG Molecular Diagnostics

        • 11.1.1 HTG Molecular Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.1.3 HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Exact Sciences Corporation

        • 11.2.1 Exact Sciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Exact Sciences Corporation Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.2.3 Exact Sciences Corporation Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 bioTheranostics (AviaraDx)

        • 11.3.1 bioTheranostics (AviaraDx) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.3.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Nuvera Biosciences

        • 11.4.1 Nuvera Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Nuvera Biosciences Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.4.3 Nuvera Biosciences Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Abbott Molecular Diagnostics

        • 11.5.1 Abbott Molecular Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.5.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 LabCorp

        • 11.6.1 LabCorp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 LabCorp Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.6.3 LabCorp Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Genoptix (Novartis)

        • 11.7.1 Genoptix (Novartis) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Genoptix (Novartis) Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.7.3 Genoptix (Novartis) Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pathway Genomics

        • 11.8.1 Pathway Genomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pathway Genomics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.8.3 Pathway Genomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Neogenomics

        • 11.9.1 Neogenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Neogenomics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.9.3 Neogenomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Cancer Genetics

        • 11.10.1 Cancer Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Cancer Genetics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.10.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Agendia

        • 11.11.1 Agendia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Agendia Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.11.3 Agendia Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Counsyl

        • 11.12.1 Counsyl Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Counsyl Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.12.3 Counsyl Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Biodesix

        • 11.13.1 Biodesix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Biodesix Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.13.3 Biodesix Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Exiqon

        • 11.14.1 Exiqon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Exiqon Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.14.3 Exiqon Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Accugenomics

        • 11.15.1 Accugenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Accugenomics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.15.3 Accugenomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Epigenomics

        • 11.16.1 Epigenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Epigenomics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.16.3 Epigenomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Invitae

        • 11.17.1 Invitae Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Invitae Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.17.3 Invitae Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Nanostring

        • 11.18.1 Nanostring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Nanostring Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.18.3 Nanostring Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 NSTG

        • 11.19.1 NSTG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 NSTG Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.19.3 NSTG Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Genomic Health

        • 11.20.1 Genomic Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Genomic Health Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.20.3 Genomic Health Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Myriad Genetics

        • 11.21.1 Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Myriad Genetics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.21.3 Myriad Genetics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Genomictree

        • 11.22.1 Genomictree Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Genomictree Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.22.3 Genomictree Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.23 Genmark Diagnostics

        • 11.23.1 Genmark Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.23.2 Genmark Diagnostics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.23.3 Genmark Diagnostics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.24 Ambry Genetics

        • 11.24.1 Ambry Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.24.2 Ambry Genetics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.24.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.25 Orion Genomics

        • 11.25.1 Orion Genomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.25.2 Orion Genomics Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.25.3 Orion Genomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.26 Flatiron Health

        • 11.26.1 Flatiron Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.26.2 Flatiron Health Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.26.3 Flatiron Health Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.27 bioMerieux

        • 11.27.1 bioMerieux Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.27.2 bioMerieux Molecular Diagnostics in Cancer Testing Product Profiles, Application and Specification

        • 11.27.3 bioMerieux Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Molecular Diagnostics in Cancer Testing Industry Investment Prospect and Risk Assessment

    • 12.1 Molecular Diagnostics in Cancer Testing Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Molecular Diagnostics in Cancer Testing Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Production Value and Growth Rate (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Production Value and Growth Rate (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate of Type 1 (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate of Type 2 (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate of Type 3 (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate of Application 1 (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate of Application 2 (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Market Size and Growth Rate of Application 3 (2017-2028)

    • Figure North America Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Molecular Diagnostics in Cancer Testing Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Molecular Diagnostics in Cancer Testing Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Molecular Diagnostics in Cancer Testing Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Molecular Diagnostics in Cancer Testing Market Share, by Manufacturer in 2021

    • Figure Global and China Molecular Diagnostics in Cancer Testing Market Share, by Manufacturer in 2022

    • Table Global Molecular Diagnostics in Cancer Testing Sales Volume, by Type (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Sales Value, by Type (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Sales Value Share, by Type (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Price Trend, by Type (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Volume, by Type (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Value, by Type (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Value Share, by Type (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Price Trend, by Type (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Sales Volume, by Application (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Sales Value, by Application (2017-2028)

    • Table Global Molecular Diagnostics in Cancer Testing Sales Value Share, by Application (2017-2028)

    • Figure Global Molecular Diagnostics in Cancer Testing Sales Value Share, by Application (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Volume, by Application (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Value, by Application (2017-2028)

    • Table China Molecular Diagnostics in Cancer Testing Sales Value Share, by Application (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Sales Value Share, by Application (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure North America Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Production, Import, Consumption and Export (2017-2022)

    • Table North America Molecular Diagnostics in Cancer Testing Sales Volume, by Type (2017-2028)

    • Table North America Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure North America Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table North America Molecular Diagnostics in Cancer Testing Sales Volume, by Application (2017-2028)

    • Table North America Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure North America Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure United States Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure United States Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Canada Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table Europe Molecular Diagnostics in Cancer Testing Sales Volume, by Type (2017-2028)

    • Table Europe Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure Europe Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table Europe Molecular Diagnostics in Cancer Testing Sales Volume, by Application (2017-2028)

    • Table Europe Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Europe Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Germany Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure UK Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure UK Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure France Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure France Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Italy Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Spain Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Poland Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Russia Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table APAC Molecular Diagnostics in Cancer Testing Sales Volume, by Type (2017-2028)

    • Table APAC Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure APAC Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table APAC Molecular Diagnostics in Cancer Testing Sales Volume, by Application (2017-2028)

    • Table APAC Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure APAC Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure China Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Japan Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure India Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure India Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Molecular Diagnostics in Cancer Testing Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Molecular Diagnostics in Cancer Testing Sales Value and Growth Rate (2017-2028)

    • Table HTG Molecular Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table HTG Molecular Diagnostics Product Profiles, Application and Specification

    • Table HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Exact Sciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Exact Sciences Corporation Product Profiles, Application and Specification

    • Table Exact Sciences Corporation Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table bioTheranostics (AviaraDx) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table bioTheranostics (AviaraDx) Product Profiles, Application and Specification

    • Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nuvera Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nuvera Biosciences Product Profiles, Application and Specification

    • Table Nuvera Biosciences Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Molecular Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Molecular Diagnostics Product Profiles, Application and Specification

    • Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table LabCorp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table LabCorp Product Profiles, Application and Specification

    • Table LabCorp Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genoptix (Novartis) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genoptix (Novartis) Product Profiles, Application and Specification

    • Table Genoptix (Novartis) Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pathway Genomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pathway Genomics Product Profiles, Application and Specification

    • Table Pathway Genomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Neogenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Neogenomics Product Profiles, Application and Specification

    • Table Neogenomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cancer Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cancer Genetics Product Profiles, Application and Specification

    • Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agendia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agendia Product Profiles, Application and Specification

    • Table Agendia Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Counsyl Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Counsyl Product Profiles, Application and Specification

    • Table Counsyl Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biodesix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biodesix Product Profiles, Application and Specification

    • Table Biodesix Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Exiqon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Exiqon Product Profiles, Application and Specification

    • Table Exiqon Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Accugenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Accugenomics Product Profiles, Application and Specification

    • Table Accugenomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Epigenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Epigenomics Product Profiles, Application and Specification

    • Table Epigenomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Invitae Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Invitae Product Profiles, Application and Specification

    • Table Invitae Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nanostring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nanostring Product Profiles, Application and Specification

    • Table Nanostring Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NSTG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NSTG Product Profiles, Application and Specification

    • Table NSTG Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genomic Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genomic Health Product Profiles, Application and Specification

    • Table Genomic Health Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myriad Genetics Product Profiles, Application and Specification

    • Table Myriad Genetics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genomictree Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genomictree Product Profiles, Application and Specification

    • Table Genomictree Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genmark Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genmark Diagnostics Product Profiles, Application and Specification

    • Table Genmark Diagnostics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ambry Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ambry Genetics Product Profiles, Application and Specification

    • Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Orion Genomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Orion Genomics Product Profiles, Application and Specification

    • Table Orion Genomics Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Flatiron Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Flatiron Health Product Profiles, Application and Specification

    • Table Flatiron Health Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table bioMerieux Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table bioMerieux Product Profiles, Application and Specification

    • Table bioMerieux Molecular Diagnostics in Cancer Testing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.